Portfolio company
nVision Medical
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops medical devices that collect cells from fallopian tubes to aid gynaecologists in the early diagnosis of ovarian cancer.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Voc Diagnostics
This company develops diagnostic instruments using machine learning and sensor technology to detect ovarian cancer from blood plasma samples for healthcare providers.
Sakura MedTech
This company develops a tampon-shaped imaging device for cervical cancer screening to replace the traditional speculum for clinicians and their patients.
Abcodia
The company develops biomarker-based blood tests and algorithms for the early detection of ovarian cancer in high-risk women.
Scanvio Medical
This company develops AI-guided ultrasound software to help gynecologists and medical centers diagnose endometriosis through real-time image analysis during standard pelvic examinations.
Teal Health
This company develops at-home cervical cancer screening devices and telehealth services for women, health systems, and employers.
AOA Diagnostics
This biotech company develops AI-enabled liquid biopsy blood tests to detect early-stage ovarian cancer in symptomatic women.
Interlace Medical
This company develops medical devices for gynaecological surgeons to remove uterine fibroids and polyps in office-based procedures.
Zilico
This company develops electrical impedance spectroscopy systems for healthcare providers to deliver real-time cervical cancer diagnostics.
